Lowering lymph node radiation when nodes clear after pre-surgery treatment
Part of Cancer, Skin clinical trials.
This trial is testing whether it's safe to reduce the amount of radiation therapy to the lymph nodes for breast cancer patients whose lymph nodes become cancer-free after neoadjuvant (pre-surgery) treatment. The goal is to see if less radiation is just as effective and causes fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with breast cancer that has spread to the lymph nodes under your arm (stage cT1-3 N1 M0) before starting treatment.
- You have already completed chemotherapy or other drug treatment before your surgery (neoadjuvant therapy).
- After surgery, the lymph nodes that were removed show no cancer (ypN0 status).
- You are generally well enough to receive radiation therapy (ECOG performance status 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well radiation therapy works for women with early-stage breast cancer who had breast-conserving surgery but did not have their underarm lymph nodes removed. It aims to understand long-term outcomes and help guide future treatment decisions.
This study looks at whether it's safe to do less extensive lymph node surgery (removing only the sentinel node instead of all lymph nodes) for breast cancer that has spread to lymph nodes, after chemotherapy has shrunk the cancer. The goal is to reduce side effects while still effectively treating the cancer.
This trial looks at whether adding targeted radiation to lymph nodes after breast surgery can lower the chance of breast cancer coming back in people with higher-risk, node-negative disease. If you qualify, you may get a planned radiation approach designed for prevention, not treatment of spread.
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
This trial tests a way to decide whether you can safely receive less radiation to lymph nodes after surgery for breast cancer that has spread to nearby nodes. If you qualify as “low risk,” the goal is to reduce radiation exposure while keeping cancer control safe.
This trial compares the benefits and risks of adding radiation therapy to the lymph nodes near the breast after surgery for people with breast cancer that has spread to a small number of lymph nodes. It may help prevent the cancer from coming back in those lymph nodes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.